1100022I SRI PCS, interventional agents - task 006 - can 8470038 - $792,692

Ended Awarded Last action

Contract number
HHSN27200006
Awardee
Awarding agency
Obligated
$5,367,346

Award facts

Opportunity
  • NIHAI2010090 Solicitation number
Contract value 100% obligated
$5,367,346.13 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Basic Research
Pricing
Cost Plus Fixed Fee
Place of performance
Menlo Park, CA 94025, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00015 $62,669
Funding Only Action P00014 -$23,494
Funding Only Action P00013 · Administration and technical support for lilly TB drug discovery initiative -$74,989
Funding Only Action P00012 · Purpose: to DE-obligate expiring FY14 funds in the amount of $6,330.28 -$6,330
Funding Only Action 11 · Purpose: to DE-obligate expiring FY13 funds in the amount of $1,483.87 -$1,484
Funding Only Action 10 · To DE-obligate expiring FY12 funds. Preclinical services for the development of interventional agents for infectious diseases administrative and technical… -$3,632
Other Administrative Action 9 · To add LOE of 80 hours. This is a new task order with period of performance 8/31/2017 to 8/30/2018. Preclinical services for the development of interventional… $683,747
Other Administrative Action 8 · To update the payment office to reflect the contract transfer. Preclinical services for the development of interventional agents for infectious diseases… $0
Funding Only Action 7 $803,239
Funding Only Action 6 · Preclinical services for the development of interventional agents for infectious diseases administrative and technical support for the lilly TB drug discovery… -$11,897
Funding Only Action 5 · The purpose of this modification is to fund 100 hours of LOE for administrative and technical support for the lilly TB drug discovery initiative $767,634
Funding Only Action 4 $800,493
Funding Only Action 3 · The purpose of this modification is to fund 164 hours of LOE for administrative and technical support for the lilly TB drug discovery initiative $793,906
Other Administrative Action 2 · The purpose of this modification is to revise article f.2. Deliveries and the statement of work. $0
Funding Only Action 1 · 1100022I SRI PCS, interventional agents - task 006 - can 8470038 MOD 1 - $784,792PRECLINICAL services for the development of interventional agents for… $784,792
Original award $792,692
Show all 16

About this award

Written by GovTribe AI ·

The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on September 19, 2011, with an obligated amount of $792,692 and a ceiling value of $5.37 million for preclinical services supporting the development of interventional agents for infectious diseases, including administration and technical support for the Lilly TB Drug Discovery Initiative.

Place of performance is Menlo Park, California. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of August 30, 2018. No set-aside was used.

Quick answers

Who was awarded contract HHSN27200006?

HHSN27200006 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 19, 2011.

How much is contract HHSN27200006 worth?

The government has obligated $5,367,346 on HHSN27200006.

Is contract HHSN27200006 an order under another contract?

Yes. HHSN27200006 is a delivery order under HHSN272201100022I, an indefinite delivery contract.

Was contract HHSN27200006 competed?

The extent of competition for HHSN27200006 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login